Breaking News, Promotions & Moves, Trials & Filings

bioAffinity Technologies Names Michael Dougherty CFO

Dougherty brings more than 20 years of financial management and business strategy experience.

Bioaffinity Technologies, Inc., a biotechnology company focused on noninvasive, accurate tests for the detection of early-stage cancer, announced that Michael Dougherty has joined the company as chief financial officer. In a statement, the company said that Dougherty is an experienced C-level executive with more than 20 years in financial management and business strategy. Dougherty will report to bioAffinity technologies President and CEO Maria Zannes. Former CFO Michael Edwards will be av...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters